Literature DB >> 16832107

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays.

P H Lalive1, T Menge, I Barman, B A Cree, C P Genain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16832107     DOI： 10.1212/01.wnl.0000223346.09426.34

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

1.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

2.  Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.

Authors:  Romain Marignier; Pascale Giraudon; Sandra Vukusic; Christian Confavreux; Jérôme Honnorat
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

3.  Successful treatment of a woman with relapsing neuromyelitis optica by interferon beta.

Authors:  Yan Xu; Yao Zhang; Jing Ye; Bin Peng; Jian-Ming Wang; Li-Ying Cui
Journal:  Neurol Sci       Date:  2011-11-27       Impact factor: 3.307

4.  Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.

Authors:  Albert Saiz; Luigi Zuliani; Yolanda Blanco; Bruno Tavolato; Bruno Giometto; Francesc Graus
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

5.  Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.

Authors:  Francesco Pisani; Mauro Mastrototaro; Andrea Rossi; Grazia Paola Nicchia; Carla Tortorella; Maddalena Ruggieri; Maria Trojano; Antonio Frigeri; Maria Svelto
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

6.  Discovery of peptoid ligands for anti-aquaporin 4 antibodies.

Authors:  Bindu L Raveendra; Hao Wu; Roberto Baccala; M Muralidhar Reddy; Jessica Schilke; Jeffrey L Bennett; Argyrios N Theofilopoulos; Thomas Kodadek
Journal:  Chem Biol       Date:  2013-03-21

7.  Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease).

Authors:  M Capobianco; S Malucchi; A di Sapio; F Gilli; A Sala; R Bottero; F Marnetto; C Doriguzzi Bozzo; A Bertolotto
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

Review 8.  Neuromyelitis optica: diagnosis, pathogenesis, and treatment.

Authors:  Bruce Cree
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

Review 9.  [Neuromyelitis optica].

Authors:  S Jarius; B Wildemann
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

10.  Aquaporins and neurodegenerative diseases.

Authors:  Eleonora Foglio; Luigi Fabrizio Rodella
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.